Women's Health News and Research

RSS

Advaxis initiates Phase 2 clinical trial of ADXS11-001 for treatment of CIN

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, initiated the Company's first clinical trial site in its randomized, single blind, placebo-controlled, Phase 2 clinical trial of ADXS11-001 for the treatment of cervical intraepithelial neoplasia.

16 Apr 2010

University of Pennsylvania School of Medicine ranked #2 among nation's research-oriented medical schools

The University of Pennsylvania School of Medicine has been ranked #2 among the nation's research-oriented medical schools, according to the annual survey by U.S. News & World Report, rising from #3 in last year's survey. The prestigious survey of the nation's 126 fully-accredited medical schools ranked Harvard University in first place and John Hopkins University third.

15 Apr 2010

New strategy, more funding needed to meet maternal, child health MDGs

"Dozens of countries are unlikely to meet" the Millennium Development Goal targets related to maternal and child health without a new strategy and an additional $20 billion each year, according to a report released Tuesday, the Canadian Press reports (Lederer, 4/14).

15 Apr 2010

Tips for protection against sun damage

It's never too early to start protecting yourself against sun damage, and if you are a teenage girl this message is especially important.

13 Apr 2010

National organizations, medical institutions join Lung Cancer Alliance to address nation's most lethal cancer

Today, Lung Cancer Alliance announced new additions to the growing list of supporters joining LCA in its "call to action" to devise a better public health strategy to address the nation's most lethal cancer.

13 Apr 2010

Drinking during adolescence increases risk of benign breast disease in young women

Girls and young women who drink alcohol increase their risk of benign (noncancerous) breast disease, says a study by researchers at Washington University School of Medicine in St. Louis and Harvard University. Benign breast disease increases the risk for developing breast cancer.

12 Apr 2010

Results of research study on the expression of KIF6 in mouse model

Celera Corporation and its collaborators at The University of Washington, WA, and Indiana University, IN, today announced the presentation of data from a research study that investigated the expression of KIF6 in a mouse Celera Corporation model. A key finding was that KIF6 was specifically expressed in macrophages and chondrocytes in mouse atherosclerotic lesions, but not in normal arteries.

12 Apr 2010

New Guardia AccessET Curved Embryo Transfer Catheter for embryo placement

Cook Medical's Women's Health division has released the Guardia AccessET Curved Embryo Transfer Catheter, featuring Cook's patented EchoTip technology. The catheter's echogenic band allows the catheter tip to be seen more clearly under ultrasound, which can allow for more accurate embryo placement.

9 Apr 2010

ASPIRE 2010 focuses on A.R.T. issues

Infertility, defined as the failure to conceive after 12 months or more of regular, unprotected intercourse, may affect as many as 15 percent of couples around the world including Asia. Like other countries, China's infertility rate is on the rise increasing from 3 percent to 15 percent in the past 20 years. It is estimated that at least 40 million Chinese couples have difficulty in having children or are actually infertile.

7 Apr 2010

Toronto Star examines cost of fighting maternal mortality, Canada's G8 initiative

Experts say that fighting maternal mortality will cost the world a total of $24 billion annually, or an additional $12 billion per year, the Toronto Star writes in an article about Canada's G8 maternal and child health initiative and a maternal health conference that is being planned ahead of the G8 meeting.

7 Apr 2010

New report assesses optimal future for REMS

Two years after the Food and Drug Administration Amendments Act of 2007 gave FDA new powers to require Risk Evaluation and Mitigation Strategies for higher risk drugs and biologics, a new report concludes that an optimal future for REMS is possible if the agency adopts a systems approach when designing REMS programs and takes advantage of new technologies -- from electronic medical records to genetic testing -- that are changing the way medicine is practiced.

5 Apr 2010

Physiotherapist-led exercise helps postnatal women reduce risk of PND

In a world first study of its kind, 161 postnatal women with no previous depressive symptoms were divided in two separate groups to test the effect of a physiotherapist-led exercise and education program on wellbeing.

3 Apr 2010

SE5-OH with Natural S-equol supplement appears to be safe for pre- and post-menopausal women

Healthy pre-and post-menopausal Japanese women who took a supplement of SE5-OH containing Natural S-equol, a novel soy germ-based ingredient under development for the management of menopausal symptoms, had measures of reproductive hormones that stayed within normal limits throughout the study.

3 Apr 2010

Men's Health digital edition on Apple iPad

Men's Health, the largest men's lifestyle magazine brand in the world, today announced that a digital edition of the publication designed exclusively for the Apple iPad will be available for purchase when the highly anticipated device goes on sale tomorrow. The release makes Men's Health one of the first consumer magazines to enter the iPad market.

3 Apr 2010

DNA patent case: US District Judge rules in favor of AMP

The Association for Molecular Pathology (AMP) is an international medical and professional association representing approximately 1,800 physicians, doctoral scientists, and medical laboratory scientists who perform laboratory testing based on knowledge derived from molecular biology, genetics, and genomics. AMP applauds US District Judge Robert Sweet's ruling in favor of the plaintiffs in the lawsuit, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al.

2 Apr 2010

U.S. Court finds Teva Pharmaceutical Industries' Seasonique patent valid and enforceable

Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Nevada has granted Teva's Motion for Summary Judgment with respect to the validity of U.S. Patent No. 7,320,969. In March 2008, Duramed, now Teva Women's Health, brought suit in the District of Nevada against Watson alleging infringement of Teva's patent as a result of Watson's filing of an Abbreviated New Drug Application (ANDA) for Seasonique®.

2 Apr 2010

Structured and supervised exercise can prevent postnatal depression, says study

Postnatal depression (PND) or baby blues are a recognized entity with millions of mothers suffering from it in varying degrees. It affects 13% of the new mothers usually within the first 3 months after the birth of the baby.

1 Apr 2010

Recipients of Pfizer Canada's third Neuropathic Pain Research Awards Competition announced

Pfizer Canada is pleased to announce the recipients of its third Neuropathic Pain Research Awards Competition, which aims to fund and support Canadian innovation within independent neuropathic pain research in the areas of basic biomedical, clinical and health sciences.

31 Mar 2010

Immigrants have trouble accessing health care in Canada

One in three South Asian, West Asian or Arab women - one of the fastest growing segments of Canada's population - say they have trouble accessing a doctor to address an urgent health concern or to monitor health problems.

31 Mar 2010

Court rules certain claims covering isolated DNA sequences in patents covering BRACAnalysis as invalid

Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.

30 Mar 2010

Women's Health News and Research

Advaxis initiates Phase 2 clinical trial of ADXS11-001 for treatment of CIN

University of Pennsylvania School of Medicine ranked #2 among nation's research-oriented medical schools

New strategy, more funding needed to meet maternal, child health MDGs

Tips for protection against sun damage

National organizations, medical institutions join Lung Cancer Alliance to address nation's most lethal cancer

Drinking during adolescence increases risk of benign breast disease in young women

Results of research study on the expression of KIF6 in mouse model

New Guardia AccessET Curved Embryo Transfer Catheter for embryo placement

ASPIRE 2010 focuses on A.R.T. issues

Toronto Star examines cost of fighting maternal mortality, Canada's G8 initiative

New report assesses optimal future for REMS

Physiotherapist-led exercise helps postnatal women reduce risk of PND

SE5-OH with Natural S-equol supplement appears to be safe for pre- and post-menopausal women

Men's Health digital edition on Apple iPad

DNA patent case: US District Judge rules in favor of AMP

U.S. Court finds Teva Pharmaceutical Industries' Seasonique patent valid and enforceable

Structured and supervised exercise can prevent postnatal depression, says study

Recipients of Pfizer Canada's third Neuropathic Pain Research Awards Competition announced

Immigrants have trouble accessing health care in Canada

Court rules certain claims covering isolated DNA sequences in patents covering BRACAnalysis as invalid

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News